Thomas Richard Kassberg, CBO & EVP at Ultragenyx Pharmaceutical Inc. (RARE), sold 79,756 shares at $32.78 ($2.6M) on 2023-10-23, disclosed to the SEC on 2023-10-24.
Scheduled sale ($2.6M) by CBO & EVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.78 | 39,878 | $1.3M | 50.0% |
| 2 | $32.78 | 39,878 | $1.3M | 50.0% |
| Total | $32.78 avg | 79,756 | $2.6M | 100% |
| Filing → |
| RARE | SELL | 2024-03-05 | $109K | — | Filing → |
| RARE | SELL | 2023-03-03 | $178K | — | Filing → |
| RARE | SELL | 2022-03-15 | $1.4M | — | Filing → |